Turmeric and Green Tea: A Recipe for the Treatment of B-Chronic Lymphocytic Leukemia

被引：22
作者：
Angelo, Laura S. [1 ]
Kurzrock, Razelle [1 ]
机构：
[1] MD Anderson Canc Ctr, Div Canc Med, Phase Clin Trials Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA
来源：
CLINICAL CANCER RESEARCH | 2009年 / 15卷 / 04期
关键词：
LIPOSOME-ENCAPSULATED CURCUMIN; FACTOR-KAPPA-B; IN-VITRO; APOPTOSIS; CANCER; PROLIFERATION; ANGIOGENESIS; CELLS; SUPPRESSION; PATHWAY;
D O I：
10.1158/1078-0432.CCR-08-2791
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Two naturally occurring compounds, curcumin, the active ingredient in the spice turmeric, and the green tea extract epigallocatechin-3-gallate, have marked effects on the apoptotic machinery in chronic lymphocytic leukemia. These results provide a preclinical foundation for future clinical use of these compounds in this disease.
引用
收藏
页码：1123 / 1125
页数：3
相关论文
共 13 条
  • [1] Phase II trial of curcumin in patients with advanced pancreatic cancer
    Dhillon, Navneet
    Aggarwal, Bharat B.
    Newman, Robert A.
    Wolff, Robert A.
    Kunnumakkara, Ajaikumar B.
    Abbruzzese, James L.
    Ng, Chaan S.
    Badmaev, Vladimir
    Kurzrock, Razelle
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4491 - 4499
  • [2] Preclinical assessment of curcumin as a potential therapy for B-CLL
    Everett, Peter C.
    Meyers, John A.
    Makkinje, Anthony
    Rabbi, Mohammed
    Lerner, Adam
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (01) : 23 - 30
  • [3] Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG
    Ghosh, Asish K.
    Kay, Neil E.
    Secreto, Charla R.
    Shanafelt, Tait D.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1250 - 1258
  • [4] Gonzales Gustavo F., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P429, DOI 10.2174/187152006778226486
  • [5] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
    Hallek, Michael
    Cheson, Bruce D.
    Catovsky, Daniel
    Caligaris-Cappio, Federico
    Dighiero, Guillaume
    Doehner, Hartmut
    Hillmen, Peter
    Keating, Michael J.
    Montserrat, Emili
    Rai, Kanti R.
    Kipps, Thomas J.
    [J]. BLOOD, 2008, 111 (12) : 5446 - 5456
  • [6] Curcumin: From ancient medicine to current clinical trials
    Hatcher, H.
    Planalp, R.
    Cho, J.
    Tortia, F. M.
    Torti, S. V.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (11) : 1631 - 1652
  • [7] Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
    Kunnumakkara, Ajaikumar B.
    Anand, Preetha
    Aggarwal, Bharat B.
    [J]. CANCER LETTERS, 2008, 269 (02) : 199 - 225
  • [8] Liposome-encapsulated curcumin - In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis
    Li, L
    Braiteh, FS
    Kurzrock, R
    [J]. CANCER, 2005, 104 (06) : 1322 - 1331
  • [9] Nuclear factor-κB and IκB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis
    Li, L
    Aggarwal, BB
    Shishodia, S
    Abbruzzese, J
    Kurzrock, R
    [J]. CANCER, 2004, 101 (10) : 2351 - 2362
  • [10] Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer
    Li, Lan
    Ahmed, Bilal
    Mehta, Kapil
    Kurzrock, Razelle
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (04) : 1276 - 1282
12